GoodRx , the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for ...
The cash price for popular weight-loss medications Wegovy and and the medication authorized for people with type 2 diabetes ...
In accordance with standard industry practice, BioRestorative plans to wait to provide investors with further updates on the Type B meeting until such time that it has received and reviewed the ...
Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare ...
More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the ...
Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?
Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce ...
Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback